State of Wyoming’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Buy
+4,598
New +$114K 0.01% 1227
2023
Q2
– Sell
-3,104
Closed -$56.6K – 1738
2023
Q1
$56.6K Buy
3,104
+804
+35% +$15.4K 0.02% 1065
2022
Q4
$47.6K Buy
+2,300
New +$63.3K 0.02% 1088
2022
Q3
– Sell
-1,611
Closed -$41K – 1861
2022
Q2
$41K Buy
1,611
+788
+96% +$19.3K 0.03% 1072
2022
Q1
$26K Buy
+823
New +$27.6K 0.01% 1369
2021
Q2
– Sell
-3
Closed – – 1213
2021
Q1
$0 Buy
+3
New +$104 ﹤0.01% 542

Other funds holding RCUS

State of Wyoming's RCUS Position: Q2 2026 in Review

State of Wyoming opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 4,598 shares worth $142K. The stake represents 0.01% of the portfolio and ranks #1227 among its holdings. This is a return to the name: State of Wyoming previously reported a position in RCUS as recently as Q1 2023.

State of Wyoming first reported a position in RCUS in Q1 2021 and has held it in 6 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • State of Wyoming held 4,598 shares of Arcus Biosciences worth $142K as of Q2 2026.
  • Arcus Biosciences was a new State of Wyoming position in Q2 2026.
  • Arcus Biosciences made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1227 holding.
  • State of Wyoming first reported a position in Arcus Biosciences in Q1 2021 and has held it in 6 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.